These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

890 related articles for article (PubMed ID: 15866308)

  • 1. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
    Beresford SA; Weiss NS; Voigt LF; McKnight B
    Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
    Banks E; Reeves G; Beral V; Bull D; Crossley B; Simmonds M; Hilton E; Bailey S; Barrett N; Briers P; English R; Jackson A; Kutt E; Lavelle J; Rockall L; Wallis MG; Wilson M; Patnick J
    Breast Cancer Res; 2006; 8(1):R8. PubMed ID: 16417651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
    Comerci JT; Fields AL; Runowicz CD; Goldberg GL
    Gynecol Oncol; 1997 Mar; 64(3):425-30. PubMed ID: 9062144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endometrial safety and bleeding with HRT: what's new?
    Sturdee DW
    Climacteric; 2007 Oct; 10 Suppl 2():66-70. PubMed ID: 17882676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endometrial response to sequential and continuous combined oestrogen-progestogen replacement therapy.
    Sturdee DW; Ulrich LG; Barlow DH; Wells M; Campbell MJ; Vessey MP; Nielsen B; Anderson MC; Bragg AJ
    BJOG; 2000 Nov; 107(11):1392-400. PubMed ID: 11117768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications for hormone replacement therapy].
    Birkhäuser MH
    Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormone replacement therapy and cancer].
    Bjørge T; Tropé C
    Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V; Banks E; Reeves G
    Lancet; 2002 Sep; 360(9337):942-4. PubMed ID: 12354487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L; Rajala T; Räihä I; Mäkinen J; Erkkola R; Helenius H
    Lancet; 1998 Dec 19-26; 352(9145):1965-9. PubMed ID: 9872245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous combined hormone replacement therapy compared with tibolone.
    Al-Azzawi F; Wahab M; Habiba M; Akkad A; Mason T
    Obstet Gynecol; 1999 Feb; 93(2):258-64. PubMed ID: 9932566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy for women previously treated for endometrial cancer.
    Edey KA; Rundle S; Hickey M
    Cochrane Database Syst Rev; 2018 May; 5(5):CD008830. PubMed ID: 29763969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.